Growth Equity

ProductPlan acquires AI-native Winware.ai, naming founder Steven Cohn its new CEO to forge an intelligence platform aimed at ending product uncertainty.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

With a hefty war chest and a veteran leadership team, Bleichroeder Acquisition Corp. II launches its search for a high-growth tech company to take public.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

With 10,000+ registered, FastBull's free gold trading contest is a hit. But is it a path to real skill or a gamified pipeline for brokers?

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

Singapore's Temasek injects another $150M into Roc360's REIT, highlighting a major institutional shift to real estate debt to fix America's aging houses.

Pan Global Resources has defined a major copper and gold resource in Spain, fueling the green energy transition and reviving a historic mining district.

HiddenLayer joins a massive $151B defense contract to secure AI systems, signaling a new era where protecting AI is critical for national missile defense.

Enterprise veteran Stacey Epstein returns to her channel roots as CEO, launching a new AI platform to redefine partner marketing for giants like Google and IBM.

A new pact between AUMOVIO and AWS leverages generative AI to slash AV development time, with driverless trucks for Aurora first in line.

Amid a capacity crisis, a new model blending AI with human oversight gains traction, promising efficiency without sacrificing the crucial element of patient care.

Sanofi is investing up to $2.56 billion in Earendil Labs' AI platform to discover next-gen bispecific antibodies for complex autoimmune diseases.

With key trials in brain and prostate cancer, Curasight heads to a top investor conference to showcase its dual-action theranostic technology.

Bitcoin miner Bitfarms sells its last Latin American asset for $30M, pivoting fully to the booming North American AI and HPC infrastructure market.

Transit-tech firm Argo gets a $1.4M boost from TheVentureCity, a fund led by a former Facebook colleague of Argo's CEO, to scale its smart city solutions.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

Commodity giant Mercuria secures copper and gold from Pucobre's El Espino mine with a $375M financing deal, betting big on Chile and green metals.

Facing soaring demand, AI robotics firm TechForce is seeking a global manufacturing partner, signaling a major shift from pilot programs to mass production.

The AI investment frenzy is shifting from GPUs to the physical world of power, cooling, and real estate, creating a new class of high-value companies.